← FDA Drug Approvals (Drugs@FDA)
GIMOTI
NDA · New Drug Application · Sponsor: QOL MEDCL · Approved 2020-06-19
Drug application
- FDA Application #
NDA209388- Application type
- New Drug Application
- Brand name
- GIMOTI
- Generic name
- METOCLOPRAMIDE HYDROCHLORIDE
- Active ingredients
- METOCLOPRAMIDE HYDROCHLORIDE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- QOL MEDCL
- Manufacturer
- Evoke Pharma, Inc.
- First approval
- 2020-06-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown